• Home
  • Arvato Systems
  • 2024 Pharma Trends Outlook: Collaboration, Market Maturity, and Digital Futures 
Whitepaper
17 Jul 2024

2024 Pharma Trends Outlook: Collaboration, Market Maturity, and Digital Futures 

PDF 6.7 MB

Our annual Pharma Trends Outlook report delves into the critical challenges facing the pharmaceutical supply chain in 2024. From protecting against supply shortages, quality management maturity, and cross-industry collaboration for sustainability and patient-centred initiatives, the pharmaceutical industry must contend with the increasing need to digitise operations with generative AI and machine-learning technologies, or risk being left behind in a changing world. In partnership with Arvato Systems, the CPHI Online 2024 Pharma Trends Outlook dissects emerging trends for 2024 with expert insight providing valuable perspectives on the rapidly changing pharmaceutical landscape.

12 Pharma Trends for 2024

  • Supply chain digitisation with generative AI
  • Pharmaceutical packaging innovations
  • Quality Management Maturity
  • Emerging biotech and R&D outsourcing trends
  • Collaboration for sustainability goals
  • Excipient development and manufacturing
  • Balancing drug pricing, manufacturing costs, and patient access
  • Science-backed evidence for herbal medicines
  • Accelerating B2B pharma marketing
  • Alzheimer's research
  • What 2023 drug approvals mean for 2024
  • An emerging Market: Middle East, Saudi Arabia, and beyond

    • Content provided by our supplier

    Arvato Systems

    • DE
    • 2023
      On CPHI since
    • 3
      Certificates
    • 1000 - 4999
      Employees
    Company types
    IT/Software solution provider
    Primary activities
    Technology
    View company profile

    Chapters

    Chapters include:

    • Chapter 1: Generative AI and supply chain digitisation
    • Chapter 2: Consumer driven packaging innovations
    • Chapter 3: Mature quality management and control
    • Chapter 4: Biotech and R&D outsourcing practices: investing and acquiring
    • Chapter 5: Collaborative sustainability by all, for all
    • Chapter 6: Making excipients great again
    • Chapter 7: Pricing, costs, and patients - balancing the pharma trinity
    • Chapter 8: Evidence-based herbal medicines
    • Chapter 9: The future of B2B pharma marketing
    • Chapter 10: Accelerating Alzheimer’s research
    • Chapter 11: What 2023 drug approvals mean for 2024
    • Chapter 12: Middle East rising: an emerging market in focus

    Other Content from Arvato Systems (3)

    • 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures

      News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures

      The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. 
      9 Jan 2024
    • Arvato Systems Joins Bundesverband Der Arzneimittel-Hersteller e.v. (German Association of Pharmaceutical Manufacturers)

      News Arvato Systems Joins Bundesverband Der Arzneimittel-Hersteller e.v. (German Association of Pharmaceutical Manufacturers)

      Arvato Systems is a new member of the German Association of Pharmaceutical Manufacturers (BAH). The BAH is considered the strongest trade association in Germany's pharmaceutical industry in terms of membership. As a provider of digital solutions in the pharmaceutical industry, Arvato Systems will now also be involved in the BAH's large partner network.
      1 Dec 2023
    • Succesful Strategies against Counterfeiting in the Pharma and Chemical Industry

      Technical Data Succesful Strategies against Counterfeiting in the Pharma and Chemical Industry

      Product counterfeiting is a common and not a small problem. This is increasingly noticeable in the pharmaceutical, chemical, and medical devices sectors. To counteract this, track & trace solutions and brand protection communication are highly important. This enables companies to respond quickly and effectively to product piracy and thus not only protect their product but also save lives.

      The brand protection study published by Arvato Systems together with Karg and Petersen once again underlines the importance of anti-piracy measures in all industries. The following sheet provides a detailed insight into the results for the industries of pharmaceutical, chemical, and medical devices.